Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 24;9(12):1806.
doi: 10.3390/children9121806.

CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male

Affiliations
Case Reports

CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male

Małgorzata Rodak et al. Children (Basel). .

Abstract

CDKL5 deficiency disorder (CDD) is a developmental encephalopathy caused by pathogenic variants in the X-linked cyclin-dependent kinase 5 (CDKL5) gene. This rare disorder occurs more frequently in females than in males. The incidence is estimated to be approximately 1: 40,000-60,000 live births. So far, 50 cases have been described in boys. The clinical course in males tends to be more severe and is often associated with death in the first or second decade of life. The authors present an unreported 2.5-year-old male patient with drug-resistant epilepsy who was diagnosed with a de novo mutation in the CDKL5 gene. First seizures developed in the fifth week of life and have progressed steadily since then. The child's psychomotor development was strongly delayed, and generalized hypotonia was noticed since birth. Brain MRI showed areas of incomplete myelination, posterior narrowing of the corpus callosum, a pineal cyst of up to 3 mm, and open islet lids. Intensive antiseizure medications (ASMs), a ketogenic diet, and steroid therapy were not successful. Short-term improvement was achieved with the implantation of a vagal nerve stimulator (VNS). Due to the progressive course of the disease, the boy requires frequent modification of ASMs.

Keywords: CDKL5 deficiency disorder; children; epileptic encephalopathy; refractory epilepsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(ac) Brain MRI in transverse planes: (a) normal in T1; (b,c) unfished myelinisation in peritrigonal white matter in (b) T2; (c) T2 FLAIR.
Figure 2
Figure 2
(ac) Brain MRI, axial (a) T2 FLAIR (b) T2, coronal (T2) unfinished myelinisation of white matter surrounding occipital horns.
Figure 3
Figure 3
(ac) Brain MRI in advanced sequences: (a) DWI diffusion weighted imaging; (b) ADC map—apparent diffusion coefficient map—areas of prolonged diffusion in peritrigonal white matter regions corresponding to unfinished myelinisation, (c) FA—fractional anisotropy sequence—symmetrical image of fibers of both hemispheres.

References

    1. Bahi-Buisson N., Bienvenu T. CDKL5-Related Disorders: From Clinical Description to Molecular Genetics. Mol. Syndr. 2011;2:137–152. doi: 10.1159/000331333. - DOI - PMC - PubMed
    1. Barbiero I., De Rosa R., Kilstrup-Nielsen C. Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder? Int. J. Mol. Sci. 2019;20:4075. doi: 10.3390/ijms20174075. - DOI - PMC - PubMed
    1. Terzic B., Davatolhagh M.F., Ho Y., Tang S., Liu Y.-T., Xia Z., Cui Y., Fuccillo M.V., Zhou Z. Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits. J. Clin. Investig. 2021;131:e143655. doi: 10.1172/JCI143655. - DOI - PMC - PubMed
    1. Olson H.E., Demarest S.T., Pestana-Knight E.M., Swanson L.C., Iqbal S., Lal D., Leonard H., Cross H., Devinsky O., Benke T.A. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review. Pediatr. Neurol. 2019;97:18–25. doi: 10.1016/j.pediatrneurol.2019.02.015. - DOI - PMC - PubMed
    1. Fehr S., Wilson M., Downs J., Williams S.J., Murgia A., Sartori S., Vecchi M., Ho G., Polli R., Psoni S., et al. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur. J. Hum. Genet. 2012;21:266–273. doi: 10.1038/ejhg.2012.156. - DOI - PMC - PubMed

Publication types

LinkOut - more resources